Sümbül, A. T., Dişel, U., Sezgin, N., Sezer, A., Köse, F., Beşen, A. A., . . . Özyılkan, Ö. (2014). Can serial monitoring of serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) levels have predictive role during Bevacizumab treatment? International Scientific Literature, Inc.
Chicago-tyylinen lähdeviittausSümbül, Ahmet Taner, Umut Dişel, Nurzen Sezgin, Ahmet Sezer, Fatih Köse, Ali Ayberk Beşen, Zehra Sümbül, Hüseyin Abalı, ja Özgür Özyılkan. Can Serial Monitoring of Serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) Levels Have Predictive Role During Bevacizumab Treatment? International Scientific Literature, Inc, 2014.
MLA-viiteSümbül, Ahmet Taner, et al. Can Serial Monitoring of Serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) Levels Have Predictive Role During Bevacizumab Treatment? International Scientific Literature, Inc, 2014.